Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients
This study has been completed.
Sponsor:
Nordic Myeloma Study Group
Collaborator:
Janssen-Cilag Ltd.
Information provided by:
Nordic Myeloma Study Group
ClinicalTrials.gov Identifier:
NCT00417911
First received: January 3, 2007
Last updated: June 17, 2010
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2010 |
| Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |